THERAVECTYS
A company developing T-cells vaccines for the treatment and prevention of infectious diseases, virally-induced cancers and cancers
2
Funding Rounds
$28.3m
Money raised
Overview
A company developing T-cells vaccines for the treatment and prevention of infectious diseases, virally-induced cancers and cancers
- Website:
- Business model: B2B
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Pi**** Ch****** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company THERAVECTYS has raised a total of $28.32m in funding over 2 rounds.
Key Insights:
- THERAVECTYS Series D round: $18.91m
- THERAVECTYS Series C round: $9.41m
THERAVECTYS Series D round
$18.91m
THERAVECTYS Series C round
$9.41m
Industries
THERAVECTYS is active in the following industries: